Early Development Research
Riverstar Research is a privately owned, state of the art research unit. Our highly trained staff is dedicated to providing rapid study start-up and recruitment, outstanding data quality and timely completion, while maintaining the highest safety standards for our patients.
Our Early Development Capabilities range from Discovery and Preclinical trials to Early Clinical Research Trials (Phase I- IIa). including, but not limited to:
- Proof of Concept
- First in Man
- Special Populations
- Dose-Ranging Studies
- Drug Interaction Studies
- Bioavailability and Bioequivalence
- Pharmacokinetic / Pharmacodynamic Studies
- Food Effect
- Ascending Dose
- Intent-To-Treat Populations
- Vaccine
- QTc / Cardiac Safety
- Toxicology
For more information about our early development unit equipment, diagnostic services or features, please follow this link and complete our contact form:
The Riverstar Advantage